Showing results (41-50 of 140) with videos related to
Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|July 1, 1982
Effects of enalapril, a new converting enzyme inhibitor, in hypertensionR K Ferguson, P H Vlasses, B N Swanson, et al.Journal of Clinical Pharmacology|July 1, 1985
A dose-titration trial of guanadrel as step-two therapy in essential hypertensionA Oren, H H Rotmensch, P H Vlasses, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1983
Disposition of intravenous and intraperitoneal cefoxitin during chronic intermittent peritoneal dialysisP H Vlasses, H D'Silva, M L Rocci, et al.American Heart Journal|March 1, 1985
Crossover comparison of captopril and propranolol as step 2 agents in hypertensionA Oren, H H Rotmensch, P H Vlasses, et al.Journal of Pharmaceutical Sciences|October 1, 1984
Relationship of morphine-induced miosis to plasma concentration in normal subjectsI L Fedder, P H Vlasses, P Mojaverian, et al.British Journal of Clinical Pharmacology|December 1, 1982
Cimetidine does not alter morphine disposition in manP Mojaverian, I L Fedder, P H Vlasses, et al.Journal of Pharmaceutical Sciences|November 1, 1984
Influence of food on the bioavailability of enalaprilB N Swanson, P H Vlasses, R K Ferguson, et al.The American Journal of Cardiology|August 1, 1984
Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertensionH H Rotmensch, M L Rocci, P H Vlasses, et al.DICP : the Annals of Pharmacotherapy|February 1, 1989
Drug interactions involving renal transport mechanisms: an overviewT Kosoglou, P H VlassesThe American Journal of Cardiology|January 1, 1984
Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitorH H Rotmensch, P H Vlasses, B N Swanson, et al.Pageof 14